ARISTADA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 14 Jun 2024)
What this means for you
Registered since 30 Jan 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Jan 2028: the §8 & §9 renewal).
Record
- Serial number
- 87189103
- Registration number
- 5392594
- Mark type
- Design + words
- Filed
- 30 Sept 2016
- Published for opposition
- 28 Feb 2017
- Registered
- 30 Jan 2018
- Next maintenance filing
- §8 & §9 renewal, due by 30 Jan 2028 (grace period to 30 Jul 2028)
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
Owner
- Alkermes Pharma Ireland Limited, Dublin, IE
- Alkermes Pharma Ireland Limited, Dublin, IE
- Alkermes Pharma Ireland Limited, Dublin, IE
Prior registrations
Board proceedings on this mark
- Extension of Time to Oppose No. 87189103 — Bristol-Myers Squibb Company v. Alkermes Pharma Ireland Limited, filed 29 Mar 2017 (Terminated)
Prosecution history
- 24 Apr 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 14 Jun 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Dec 2023 — TEAS SECTION 8 & 15 RECEIVED
- 30 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 29 Dec 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Dec 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Dec 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Dec 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Dec 2017 — ASSIGNED TO LIE
- 15 Dec 2017 — ASSIGNED TO LIE
- 07 Dec 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Nov 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED